Home › Type 2 Diabetes › Michigan
Type 2 Diabetes clinical trials in Michigan
26 studies for Type 2 Diabetes are looking for participants at sites in Michigan.
Cities in Michigan
- Ann Arbor10 studies
- Troy6 studies
- Detroit5 studies
- Farmington Hills5 studies
- Dearborn3 studies
- Flint3 studies
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Aa Mrc Llc, Flint
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Henry Ford Hospital, Detroit
- Trinity Health Michigan Heart, Ypsilanti
RecruitingHealthy volunteers welcome
Ages 55 and older · All sexes · Updated Sep 28, 2026 · NCT06112418A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Revival Research Institute, LLC, Dearborn
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Farmington Hills
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Northern Pines Health Center - Buckley, Buckley
- Revival Research Institute, LLC - Dearborn, Dearborn
- Arcturus Healthcare - Troy Internal Medicine Research Division, Troy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07754461A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Southfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Revival Research Institute, LLC - Dearborn, Dearborn
- Aa Mrc Llc, Flint
- Elite Research Center, LLC, Flint
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Elixia Health - Michigan Kidney Consultants, LLC - Elixia - PPDS, Pontiac
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 15, 2026 · NCT07340320Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- University of Michigan, Ann Arbor
- Elixia Michigan Kidney Consultants, Pontiac
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 11, 2026 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Southfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Great Lakes Research Inst., Southfield
RecruitingPhase 3
Ages 10 to 18 · All sexes · Updated Sep 9, 2026 · NCT07282613Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Oakland Medical Research Center, Troy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07296484Mechanisms of Fatigability With Diabetes
- University of Michigan, Ann Arbor
Recruiting
Ages 30 to 85 · All sexes · Updated Sep 1, 2026 · NCT04442451AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Henry Ford Health System, Detroit
- Elite Research Center, Flint
- Arcturus Healthcare, PLC., Troy
- and 1 more
RecruitingPhase 3
Ages 45 and older · All sexes · Updated Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Troy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Southfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662044Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Henry Ford Health System, Detroit
Recruiting
Ages 18 to 80 · All sexes · Updated Aug 28, 2026 · NCT07599982Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Henry Ford Health Systems, Detroit
Recruiting
Ages 14 to 75 · All sexes · Updated Aug 3, 2026 · NCT07579702Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Henry Ford Health, Detroit
Recruiting
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07521475Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
- University of Michigan, Ann Arbor
RecruitingObservational studyHealthy volunteers welcome
Ages 14 to 18 · All sexes · Updated Jul 13, 2026 · NCT06007404Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- University of Michigan, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT06906627Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- University of Michigan, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT06906640Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
- University of Michigan, Ann Arbor
Recruiting
Ages 18 and older · Men · Updated Jun 12, 2026 · NCT06574035Mechanism of SGLT2 Inhibition in the Kidney
- University of Michigan, Ann Arbor
RecruitingPhase 4Mentions payment for participants
Ages 18 to 80 · All sexes · Updated Jun 11, 2026 · NCT06291155HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Arcturus Healthcare, PLC, Troy Internal Medicine Research Division, Troy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07546929RESET System Pivotal Trial (Rev F)
- Michigan Medicine, Division of Gastroenterology and Hepatology, Ann Arbor
Recruiting
Ages 22 to 65 · All sexes · Updated Jul 18, 2024 · NCT04101669From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.